
1629229-37-3 Fezolinetant
CAS: 1629229-37-3
MF: C16H15FN6OS
MW: 358.39
Einecs:
MDL No.:MFCD30532641
Pwopriyete
Aparans blan ak jòn solid
Pwen bouyi: 623. 0 ± 65. 0 degre
Dansite 1.56 ± 0. 1 g/cm3
Depo tanperati. Magazen nan -20 degre
solubility dmso: 2 0. 0 (max conc. mg/ml); 55.8 (max conc. mm)
PKA {{0}}. 28 ± 0.40
Aplikasyon:
Fezolinatant (non komès Veozah) se yon medikaman ki pa ormon ki itilize pou trete sentòm vasomotor modere ak grav (VMs) ki te koze pa menopoz. Li se yon antagonist reseptè NK3 ki prensipalman kontwole aktivite nerono nan sant la thermoregulatory pa antagonize neurokinin la -3 reseptè (NK3 reseptè), kidonk soulaje sentòm VMS
Sinonim:
Fezolinetant
1629229-37-3
ESN364
Veozah
ESN -364
fezolinetantum
A2693
(4- fluorophenyl)-[(8r) -8- methyl -3- (3- methyl -1, 2, 4- yl) -6, 8- dihydro -5 h- [1,2,4] triazolo [4, 3- a] pyrazin -7- yl] methanone
(R)-(4- fluorophenyl) (8- methyl -3- (3- methyl -1, 2, 4- thiadiazol -5- } yl) -5, 6- dihydro- [1,2,4] triazolo [4, 3- a] pirazin -7 (8h) -yl) methanoneone
A-2693
Kòm -3472693-00
Metanon, ((8r) -5, 6- dihydro -8- methyl -3- (3- methyl -1, 2, 4- thiadiazol {{9} yl) -1, 2, 4- triazolo (4, 3- a) Pyrazin -7 (8h) -yl) (4- fluorophenyl)-
(4- fluorophenyl) ((8r) -5, 6- dihydro -8- methyl -3- (3- methyl -1, 2, {{{{{ {9}} thiadiazol -5- yl)-(1,2,4) Triazolo (4, 3- a) Pyrazin {{17}
Veoza
Vezoa
GTPL10422
ESN 364
Baj popilè: 1629229-37-3 Fezolinetant, Lachin 1629229-37-3 Konpayi fabrikasyon Fezolinetant, Swèd

